NCT00392444View on ClinicalTrials.gov

Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Advanced Malignant MesotheliomaRecurrent Malignant Mesothelioma
Interventions
DRUG

sunitinib malate

Given orally

Trial Locations (1)

K7L 3N6

National Cancer Institute of Canada Clinical Trials Group, Kingston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00392444 - Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma | Biotech Hunter | Biotech Hunter